Company Filing History:
5 out of 330 
1 out of 18 
1 out of 236 
Years Active: 1998-2006
Title: Udo Hedtmann: Innovating Therapeutics from Frankfurt-am-Main
Introduction
Udo Hedtmann, a prominent inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, Hedtmann’s work primarily focuses on innovations that seek to improve therapeutic outcomes for various medical conditions.
Latest Patents
One of Udo Hedtmann's latest inventions includes a crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide. This invention relates to a specific crystal modification of the compound and outlines the processes for its preparation and use. The applications of this crystal form extend to the treatment of acute immunological episodes, including sepsis, allergies, and autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. Furthermore, his invention has implications for treating a variety of cancers, including lung cancer, leukemia, and breast cancer, among others.
Career Highlights
Throughout his career, Udo Hedtmann has worked with reputable organizations such as Aventis Pharma Deutschland GmbH and Hoechst Marion Roussel Deutschland GmbH. His experience in these companies has shaped his innovative approaches in developing therapeutic solutions that address complex health issues.
Collaborations
Hedtmann has had the opportunity to collaborate with esteemed colleagues, including Holger Faasch and Uwe Westenfelder. Together, they have synergized their expertise to advance research and development in pharmaceutical inventions.
Conclusion
Udo Hedtmann continues to exemplify ingenuity in the realm of therapeutics. His active contributions through impactful patents highlight a commitment to enhancing medical treatments that can significantly improve patient outcomes. As his career progresses, the medical field eagerly awaits the next phase of his innovative journey.